PRO-DEX INC
PDEXNASDAQTrading Snapshot
- Day Range
- $68.31 – $70.30
- 52-Week Range
- $23.47 – $77.00
- Volume
- $1.93B
- Avg Volume
- $2.13B
- Shares Outstanding
- 3.2M
- Next Earnings
- Oct 31, 2026
Fundamentals Snapshot
- Annual Revenue
- $78M
- Last Q Revenue
- $20M
- P/E Ratio
- 17.0
- P/S Ratio
- 3.0x
- EPS (TTM)
- $4.12
- Dividend Yield
- —
- Dilution (1yr)
- +0.4%
Why Investors Own PDEX
- ✓High-growth profile — revenue up +19.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 57% gross margin and 19% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
PRO-DEX INC
PDEX
StockOtter · stockotter.spaceAbout PRO-DEX INC
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Best Momentum Stocks to Buy for September 18th
PDEX, APH and RELY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 18th, 2026.
New Strong Buy Stocks for September 18th
PGY, OPHC, PDEX, TRV and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 18th, 2026.
Bank of New York Mellon Corp Invests $678,000 in Pro-Dex, Inc. $PDEX
Bank of New York Mellon Corp bought a new stake in shares of Pro-Dex, Inc. (NASDAQ: PDEX) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 11,587